Drug Regulation Amendments
We are very pleased to share with you that the Drug Regulation, O. Reg. 203/94 (General) made under the Chiropody Act, 1991, with amendments, was filed with the Registrar of Regulations on May 15, 2023. Notably, the Drug Regulation has been amended to expand the drug categories and drugs available to eligible registrants. As many of you know, this has been a long process and the College offers special thanks to the Standing Drug Committee composed of: Cesar Mendez, Jannel Somerville, Jim Daley and Peter Stavropoulos for their tireless efforts to make the new amended regulation a reality.
The link to the new amended Drug Regulation can be found here: O. Reg. 203/94: GENERAL (ontario.ca)
The link to view the amendments only can be found here: O. Reg. 93/23: GENERAL (ontario.ca)
The following registrants have, effective immediately, full prescribing privileges under the newly amended Drug Regulation:
- All American trained DPMs, including DPMs who are registered as chiropodists;
- All Michener graduates from 2010 and beyond; and
- All registrants who have provided proof of successful completion of the Michener’s Continuing Education Pharmacology course available as of January 2022.
The following registrants have, effective immediately, partial prescribing privileges under the newly amended Drug Regulation restricted to Schedule 2 – Drugs that may be prescribed by a member (Topical and Oral) with the EXCEPTIONS of: the Oral Azole Agents (Itraconazole, Fluconazole), the Oral Allylamine Agents (Terbinafine) and the Oral Second Generation Anti-Histamines (Cetirizine):
- All Michener graduates from 2009 and earlier who have prescribing privileges under the former Drug Regulation; and
- All registrants who are not Michener graduates who have prescribing privileges under the former Drug Regulation.
Any member who wishes to have full prescribing privileges under the newly amended Drug Regulation who does not currently must successfully complete the pharmacology course at the Michener. Here is the link for the Michener Continuing Education Pharmacology course. The cost for the course at the time of this email is $1050.00 and the course is 16 weeks in duration.
Registrants are reminded of their professional obligation to restrict their practice, including prescribing, to areas within which they have competence to practice.
In the coming weeks the College will notify eligible registrants directly as to their prescribing privileges under the amended Drug Regulation. A notation on the public register will denote what prescribing privileges a registrant has pursuant to the newly amended regulation with categories of: prescribing (meaning full prescribing); partial prescribing (Schedule 2 with the exceptions noted above); and none (members who have no prescribing privileges).
If you have any questions please contact the College at firstname.lastname@example.org.